BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Horizon Discovery Enters Into Agreement With Roche Diagnostics to Support the Development of Immunohistochemistry Assays for Oncology

  Under the terms of the agreement, Horizon will develop and provide Reference Standard material expressing NTRK fusion biomarkers.

  December 18, 2017

   · 

  2 min read
• Business

  Concept Life Sciences Achieves Record Profits and Strengthens Senior Team

  Concept Life Sciences today announced a successful financial year, ending 2017 with revenues in excess of $65m/£49m and alsowelcomes Dr Andrew Scott as Head of Bioassay Development and Screening, and Magalie Ferbach as Business Development Director for Southern and Central Europe.

  December 18, 2017

   · 

  2 min read
• Policy

  Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Yervoy (ipilimumab) for the Treatment of Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma

  Bristol-Myers Squibb announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the approval of Yervoy (ipilimumab) for pediatric patients 12 years of age and older who have unresectable or metastatic melanoma.

  December 18, 2017

   · 

  17 min read
• Drug Development

  Can-Fite Reports on the Progress of Its Phase II Liver Cancer With Namodenoson

  The Company previously announced in August that it had successfully completed enrollment of 78 patients.

  December 18, 2017

   · 

  6 min read
• Business

  Revive Therapeutics Enters into Collaboration Agreement with Health Canada Licensed Dealer for Medical Cannabis and US FDA Approved Laboratory

  The Agreement with Chemi Pharma strengthens Revive’s ambition in becoming a leader in the medical cannabis market.

  December 18, 2017

   · 

  6 min read
• Business

  Xanthic Biopharma Limited and Aurquest Resources Inc. Announce Closing of RTO Transaction and New Private Placement

  Pursuant to the terms of the Definitive Agreement, Aurquest acquired all of the issued and outstanding common shares of Xanthic from the Xanthic Shareholders.

  December 18, 2017

   · 

  3 min read
• 

  Drug Development

  Novocure Receives FDA IDE Approval for Its PANOVA 3 Phase III Pivotal Clinical Trial in Advanced Pancreatic Cancer

  NovoCure announced today that it has received a FDA Investigational Device Exemption (IDE) approval to initiate its PANOVA 3 clinical trial.

  December 18, 2017

   · 

  5 min read
• DarioHealth Gains Regulatory Approval in Australia for iPhone 7, iPhone 8, and iPhone X Smart Glucose Meter

  The regulatory approval ensures that consumers in the Australian market will be able to receive the same quality user experience with DarioHealth on the latest Apple devices, including the brand-new iPhone 8 and iPhone X.

  December 18, 2017

   · 

  4 min read
• Pharm Country

  Citius Announces $6M Registered Direct Offering Priced at-the-Market

  The closing of the offering is expected to take place on or about December 19, 2017, subject to the satisfaction of customary closing conditions.

  December 18, 2017

   · 

  5 min read
• Biotech Beach

  Biocept Signs In-Network Provider Agreement With Wellmark Blue Cross Blue Shield Expanding Coverage for its Target Selector Platform in Iowa and South Dakota

  The agreement marks Biocept’s third Blue Cross Blue Shield contract and enables patients diagnosed with cancer the ability to access the Company’s proprietary testing services in-network under their Wellmark health plan.

  December 18, 2017

   · 

  3 min read